Effects of Augmented Reality (AR) and Transcranial Direct Current Stimulation (tDCS)
1 other identifier
interventional
28
1 country
1
Brief Summary
The aim of this randomized controlled trial is to determine the effects of Augmented Reality (AR)-based balance training on improving balance and postural control in chronic stroke survivors and whether the addition of transcranial Direct Current Stimulation (tDCS) to AR training produces superior outcomes compared to AR training alone.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable stroke
Started May 2026
Shorter than P25 for not_applicable stroke
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 20, 2026
CompletedFirst Submitted
Initial submission to the registry
June 1, 2026
CompletedFirst Posted
Study publicly available on registry
June 5, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 20, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 20, 2026
June 5, 2026
June 1, 2026
5 months
June 1, 2026
June 1, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Berg Balance Scale (BBS)
Berg Balance Scale is a performance-based measure used to assess static and dynamic balance abilities in stroke survivors. It consists of 14 functional tasks such as standing, reaching, turning, and transfers, performed under supervision. Scoring: Each item is rated on a 5-point ordinal scale (0-4), where 0 = unable to perform and 4 = performs independently. The maximum score is 56 points. Interpretation: * 0-20 = High risk of falls * 21-40 = Moderate risk of falls * 41-56 = Low risk of falls
Baseline-4 Weeks-8 Week-1 Month Follow Up
Timed Up and Go Test (TUG)
The TUG test measures basic functional mobility and is a quick, simple tool to evaluate fall risk and dynamic balance. Participants are asked to stand up from a chair, walk 3 meters, turn around, walk back, and sit down. Scoring: The time (in seconds) taken to complete the task is recorded. * \<10 seconds = Completely mobile * \<20 seconds = Mostly independent * 20-29 seconds = Variable mobility * ≥30 seconds = Impaired walking, high fall risk
Baseline-4 Weeks-8 Week-1 Month Follow Up
Postural Assessment Scale for Stroke (PASS)
The PASS is a clinical tool specifically designed to assess postural control in stroke patients. It consists of 12 items divided into two sections: Maintaining Posture (sitting, standing, lying) and Changing Posture (transfers, standing up, picking objects). Scoring: Each item is scored on a scale of 0-3, with a total maximum score of 36 points. * Higher scores = Better postural control * Lower scores = Higher risk of falls and dependence in mobility
Baseline-4 Weeks-8 Week-1 Month Follow Up
Functional Reach Test
Predicts fall risk by measuring dynamic trunk reach. Normal value = 22.7 cm. ICC = 0.80-0.88 Inter-Class = 0.94-0.97 Test-retest = 0.84-0.86 (p\<0.001)
Baseline-4 Weeks-8 Week-1 Month Follow Up
Fugl-Meyer Assessment (FMA) (LE)
Evaluates lower extremity motor recovery post-stroke, including reflexes, voluntary movement, and coordination.
Baseline-4 Weeks-8 Week-1 Month Follow Up
Activities-specific Balance Confidence (ABC) Scale
Assesses confidence in performing ambulatory activities. 16-item self-report questionnaire. Test-retest ICC = 0.91
Baseline-4 Weeks-8 Week-1 Month Follow Up
Study Arms (2)
Augmented reality Combined with TDCs + Convention therapy
EXPERIMENTALParticipants will receive 12 sessions over 4 weeks (3 sessions per week), each lasting 60 minutes. Transcranial Direct Current Stimulation (tDCS) will be applied for 15 minutes immediately before the AR balance training session. Each session will consist of 30 minutes of interactive AR-based balance games with real-time visual and auditory feedback, followed by 15 minutes of conventional therapy targeting balance and mobility. All sessions will be supervised by a physiotherapist, and participants' queries during the training will be addressed.
Augmented reality with Sham+ Convention therapy
ACTIVE COMPARATORThe Control group will undergo 12 sessions over 4 weeks (3 sessions per week), with each session lasting 60 minutes, consisting of 30 minutes of interactive balance tasks through AR-based games with real-time visual and auditory feedback, 15 minutes of conventional physiotherapy-based balance and mobility training, and 15 minutes of sham stimulation using the tDCS setup without active current flow.
Interventions
Participants will receive 12 sessions over 4 weeks (3 sessions per week), each lasting 60 minutes. Transcranial Direct Current Stimulation (tDCS) will be applied for 15 minutes immediately before the AR balance training session. Each session will consist of 30 minutes of interactive AR-based balance games with real-time visual and auditory feedback, followed by 15 minutes of conventional therapy targeting balance and mobility. All sessions will be supervised by a physiotherapist, and participants' queries during the training will be addressed.
The participants in this group will undergo 12 sessions over 4 weeks (3 sessions per week), with each session lasting 60 minutes, consisting of 30 minutes of interactive balance tasks through AR-based games with real-time visual and auditory feedback, 15 minutes of conventional physiotherapy-based balance and mobility training, and 15 minutes of sham stimulation using the tDCS setup without active current flow.
Eligibility Criteria
You may qualify if:
- Balance impairment confirmed by Berg Balance Scale (BBS) score 21-44.
- Age between 18-90 years.
- Mild or no spasticity in lower limb (MAS ≤ 2)
- have sufficient cognition to follow the instructions provided by the therapists and the computer.
You may not qualify if:
- Individuals with implanted electronic devices (e.g., pacemakers), due to interaction risk with tDCS
- Other medical or psychological conditions affecting participation (e.g., severe pain, epilepsy, pacemaker).
- Patients with severe cognitive deficits or visual impairments
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Railway General Hospital
Rawalpindi, Punjab Province, 44000, Pakistan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Aaleen Fatima, MS-NMPT*
Riphah International Unversity
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 1, 2026
First Posted
June 5, 2026
Study Start
May 20, 2026
Primary Completion (Estimated)
October 20, 2026
Study Completion (Estimated)
November 20, 2026
Last Updated
June 5, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share